Benjamin Goldman-Israelow, MD/PhD

Dr. Benjamin Goldman-Israelow is an Assistant Professor in the Department of Internal Medicine in the section of Infectious Diseases. He obtained his AB in Biology from Washington University in St. Louis and his MD and PhD degrees from The Icahn School of Medicine at Mount Sinai. He joined Yale internal medicine in the ABIM Short Track Pathway, completing residency and Infectious Diseases fellowship training. During fellowship, Dr. Goldman-Israelow joined the laboratory of Dr. Akiko Iwasaki for his postdoctoral studies. There, he has studied SARS-CoV-2 infection, pathogenesis, and immunity in both patients and pre-clinical models. His work has led to the development of one of the first mouse models to study SARS-CoV-2, the identification of immunologic factors contributing to COVID-19 pathogenesis and protection, and the development of a novel mucosal vaccine strategy that protects against pathology and transmission.

Dr. Goldman-Israelow is a practicing infectious diseases physician and also conducts biomedical research. His lab is focused on understanding the development of mucosal immune memory to emerging and endemic respiratory pathogens. Working through the lenses of natural infection and vaccination, the Israelow lab aims to better understand the correlates of protection and transmission of pandemic-associated pathogens, and leverage this research to develop the next generation of mucosal vaccines and therapeutics.